Article Figures & Data

Figures

  • Figure 2.

    Relative Risk of CV Events in Treated Patients.

    Reproduced from Gallwitz B et al. 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial. Lancet 2012; 380(9840):475–483. With permission from Elsevier.